RIS ID

111471

Publication Details

Flitcroft, K. L., Irwig, L. M., Carter, S. M., Salkeld, G. P. & Gillespie, J. A. (2012). Colorectal cancer screening: Why immunochemical fecal occult blood tests may be the best option. BMC Gastroenterology, 12 (1), 183-1-183-6.

Abstract

Background: There are many test options available for colorectal cancer screening. The choice of test relates to the objectives of those offering or considering screening.Discussion: While all screening programs aim to detect disease early in order to improve the length and/or quality of life for the individual, some organizations and individuals prefer screening tests that offer the opportunity for cancer prevention. Others favor maximizing participation or the opportunity for shared decision-making, including discussion of information on test quality and availability. We propose three additional objectives for screening: minimizing harms, optimizing economic efficiency and maximizing equity of access to screening.Summary: Applying these objectives to colorectal cancer screening, we advocate the use of immunochemical FOBTs as the preferred screening strategy, as it satisfies all three of these important objectives.

Share

COinS
 

Link to publisher version (DOI)

http://dx.doi.org/10.1186/1471-230X-12-183